Reversible peripheral neuropathy induced by a single administration of high-dose paclitaxel

Neurology

Volumn 51, Issue 3, 1998, Pages 868-870

  Iniguez C ^a   Larrode P ^a   Mayordomo, J I ^a   Gonzalez P ^a   Adelantado, S ^a   Yubero, A ^a   Tres A ^a   Morales, F ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HUMAN; HYPERSENSITIVITY; MALE; MUCOSA INFLAMMATION; NEUROTOXICITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0344589360     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.3.868     Document Type: Article

References (10)

1. Schiller JH, Storer B, Tutsch K, et al. A phase I trial of 3-hour infusions of paclitaxel (Taxol) with or without granulocyte colony-stimulating factor. Semin Oncol 1994;21(suppl 8):9-14.
2. Stemmer SM, Cagnoni PJ, Shpall EJ, et al. High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: a phase I trial. J Oncol 1996; 14:1463-1472.
3. Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 1993;20(suppl 3):1-15.
4. Lipton RB, Apfel SC, Dutcher JP, et al. Taxol produces a predominantly sensory neuropathy. Neurology 1989;39:368-373.
5. Cavaletti G, Bogliun G, Marzorati L, et al. Peripheral neurotoxicity of Taxol in patients previously treated with cisplatin. Cancer 1995;75:1141-1150.
6. Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from Taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 1994;35:304-311.
7. Sahenk Z, Barohn R, New P, Mendell JR. Taxol neuropathy: electrodiagnostic and sural nerve biopsy findings. Arch Neurol 1994;51:726-729.
8. Mayordomo JI, Yubero A, Cajal R, et al. Phase I trial of high-dose paclitaxel in combination with cyclophosphamide, thiotepa and carboplatin with autologous peripheral blood stem cell rescue. Proc ASCO 1997;16:102A.
9. Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 1993;68:748-752.
10. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590-596.